Aged Lewis rats exposed to low and moderate doses of rotenone are a good model for studying the process of protein aggregation and its effects upon central nervous system cell physiology

被引:12
作者
Almeida, Michael F. [1 ]
Silva, Carolliny M. [1 ]
D'Unhao, Aline M. [1 ]
Ferrari, Merari F. R. [1 ]
机构
[1] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
protein aggregates; rats; neurodegeneration; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYSFUNCTION; IN-VIVO; OLIGOMERS; TAU; STRESS;
D O I
10.1590/0004-282X20160121
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cell physiology is impaired before protein aggregation and this may be more relevant than inclusions themselves for neurodegeneration. The present study aimed to characterize an animal model to enable the analysis of the cell biology before and after protein aggregation. Ten-month-old Lewis rats were exposed either to 1 or 2 mg/kg/day of rotenone, delivered subcutaneously through mini-pumps, for one month. Hyperphosphorylated TAU, alpha-synuclein, amyloid-beta peptide and protein carbonylation (indicative of oxidative stress) were evaluated in the hippocampus, substantia nigra and locus coeruleus through immunohistochemistry or western blot. It was found that 2 mg/kg/day rotenone increased amyloid-beta peptide, hyperphosphorytation of TAU and alpha-synuclein. Rotenone at 1mg/kg/day did not alter protein levels. Protein carbonylation remained unchanged. This study demonstrated that aged Lewis rats exposed to a low dose of rotenone is a useful model to study cellular processes before protein aggregation, while the higher dose makes a good model to study the effects of protein inclusions.
引用
收藏
页码:737 / 744
页数:8
相关论文
共 27 条
[1]   Mitochondrial complex I inhibition depletes plasma testosterone in the rotenone model of Parkinson's disease [J].
Alam, M ;
Schmidt, WJ .
PHYSIOLOGY & BEHAVIOR, 2004, 83 (03) :395-400
[2]   Classic and New Animal Models of Parkinson's Disease [J].
Blesa, Javier ;
Phani, Sudarshan ;
Jackson-Lewis, Vernice ;
Przedborski, Serge .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
[3]   Protein aggregation containing beta-amyloid, alpha-synuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure [J].
Chaves, Rodrigo S. ;
Melo, Thaiany Q. ;
Martins, Stephanie A. ;
Ferrari, Merari F. R. .
BMC NEUROSCIENCE, 2010, 11
[4]   Protein carbonylation in human diseases [J].
Dalle-Donne, I ;
Giustarini, D ;
Colombo, R ;
Rossi, R ;
Milzani, A .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (04) :169-176
[5]   Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases [J].
Fang, Cheng ;
Bourdette, Dennis ;
Banker, Gary .
MOLECULAR NEURODEGENERATION, 2012, 7
[6]   Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia [J].
Ferrer, Isidro .
PROGRESS IN NEUROBIOLOGY, 2012, 97 (01) :38-51
[7]   Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone [J].
Fleming, SM ;
Zhu, CN ;
Fernagut, PO ;
Mehta, A ;
DiCarlo, CD ;
Seaman, RL ;
Chesselet, MF .
EXPERIMENTAL NEUROLOGY, 2004, 187 (02) :418-429
[8]   Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity [J].
Gaugler, Meret Nora ;
Genc, Ozgur ;
Bobela, Wojciech ;
Mohanna, Safa ;
Ardah, Mustafa Taleb ;
El-Agnaf, Omar Mukhtar ;
Cantoni, Marco ;
Bensadoun, Jean-Charles ;
Schneggenburger, Ralf ;
Knott, Graham W. ;
Aebischer, Patrick ;
Schneider, Bernard Laurent .
ACTA NEUROPATHOLOGICA, 2012, 123 (05) :653-669
[9]   Neuropathology underlying clinical variability in patients with synucleinopathies [J].
Halliday, Glenda M. ;
Holton, Janice L. ;
Revesz, Tamas ;
Dickson, Dennis W. .
ACTA NEUROPATHOLOGICA, 2011, 122 (02) :187-204
[10]   Amyloid-β Protein Modulates Insulin Signaling in Presynaptic Terminals [J].
Heras-Sandoval, David ;
Ferrera, Patricia ;
Arias, Clorinda .
NEUROCHEMICAL RESEARCH, 2012, 37 (09) :1879-1885